Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has received an average rating of “Hold” from the ten research firms that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $102.00.
ITGR has been the subject of several analyst reports. Truist Financial boosted their price objective on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a report on Friday, February 20th. Wells Fargo & Company lifted their price target on Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Raymond James Financial restated an “outperform” rating and issued a $101.00 price objective on shares of Integer in a research report on Monday, February 23rd. Wall Street Zen cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Finally, Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th.
Read Our Latest Stock Analysis on Integer
Insider Transactions at Integer
Institutional Investors Weigh In On Integer
Several institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after buying an additional 837 shares during the last quarter. Millennium Management LLC increased its stake in shares of Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp increased its stake in shares of Integer by 79,888.9% in the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after acquiring an additional 7,190 shares during the last quarter. United Services Automobile Association purchased a new position in shares of Integer during the 1st quarter worth $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Integer by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock valued at $12,900,000 after acquiring an additional 4,873 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.
Integer Price Performance
NYSE ITGR opened at $85.45 on Friday. The firm’s fifty day simple moving average is $85.73 and its two-hundred day simple moving average is $84.36. The firm has a market capitalization of $2.94 billion, a P/E ratio of 29.77, a P/E/G ratio of 1.44 and a beta of 0.75. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69. Integer has a 12-month low of $62.00 and a 12-month high of $127.56.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.06. The business had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The company’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the company earned $1.43 earnings per share. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Analysts forecast that Integer will post 6.01 EPS for the current fiscal year.
Integer Company Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
